Generated by AI
TELA Bio, Inc. is a commercial-stage medical technology company focused on soft-tissue reconstruction solutions for surgeons and healthcare providers. The company develops and markets reinforced tissue matrix products designed for hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery, with an emphasis on preserving and restoring the patient’s own anatomy. Its OviTex portfolio includes products for open, laparoscopic, and robotic procedures, as well as configurations tailored to different surgical needs in general surgery and reconstructive care. TELA Bio also supports applications that aim to reduce reliance on permanent synthetic materials while leveraging the body’s natural healing response. Headquartered in Malvern, Pennsylvania, TELA Bio serves the medical device market through products that address unmet needs in modern soft-tissue repair.
Website1 Great Valley Parkway
Malvern, PA, 19355
United States
The latest articles about TELA.
Summary of Mar 21's posts. Generated by AI.
No summary yet.
No summary yet.
Summary of Nov 8's posts. Generated by AI.
Investors talking about TELA also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.